China Campaigns To Counter Criticism as Fake-Drug Source
This article was originally published in PharmAsia News
Executive Summary
China is attempting to counter criticism it is the source of a flood of fake or shoddy drugs around the world. A deputy commissioner of the State FDA called a news conference to press the Chinese case that it exports quality drug products and that they are safe. He said China's 4,708 pharmaceutical companies are not responsible for counterfeit drugs. If any fake drugs are being produced in China, he said, they are from illegal companies. (Click here for more
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.